メディア
ニュース一覧
メディア
掲載論文
LATEST
2021
Aug 2, 2022
ENDPOINTS
With some neuro targets in mind, AbbVie gets Sosei's drug discovery engine churning again
記事を見る
Jul 22, 2022
ENDPOINTS
Sosei Heptares partners with a UK-based cancer research organization to bring its drug to trial
記事を見る
Jan 6, 2022
Fierce Biotech
Verily links up with Sosei Heptares for GPCR drug discovery
記事を見る
Jan 6, 2022
PharmaTimes
Sosei Heptares and Verily to collaborate on immune-mediated disease treatments
記事を見る
Jan 6, 2022
Endpoints News
Sosei and Verily partner on GPCRs; ObsEva touts PhIII data in endometriosis pain - by Paul Schloesser
記事を見る
Nov 22, 2021
Fierce Biotech
Neurocrine pens $2.6B biobucks pact with Sosei Heptares for next-gen neuro targets - Biotech Neurocrine pens $2.6B biobucks pact with Sosei Heptares for next-gen neuro targets - by Ben Adams
記事を見る
Nov 22, 2021
Endpoints News
Bouncing back from a PhII flop in schizophrenia, Neurocrine steers into the busy M4/M1 pathway with a $100M cash deal - by John Carroll
記事を見る
Nov 22, 2021
BioCentury
Sosei finds second partner for muscarinic neurology assets in Neurocrine - by Stephen Hansen
ダウンロードPDF
Nov 22, 2021
BioWorld
Sosei, Neurocrine ink $2.6B neuropsychiatric collaboration - by Nuala Moran
ダウンロードPDF
LATEST
2021